本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CM Life Sciences III Inc

8.69
0.0000
成交量:- -
成交额:- -
市值:6.00亿
市盈率:- -
高:8.69
开:8.69
低:8.69
收:8.69
数据加载中...
2022/05/13

重要事件披露

8-K - Current report
2022/03/23

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/23

重要事件披露

8-K - Current report
2022/02/23

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/10

重要事件披露

8-K - Current report
2021/12/30

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/12/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/12/27

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/12/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/12/21

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2021/12/20

重要事件披露

8-K - Current report
2021/12/17

重要事件披露

8-K - Current report
2021/12/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/08

企业合并公告

425 - Prospectuses and communications, business combinations
2021/12/08

企业合并公告

425 - Prospectuses and communications, business combinations
2021/12/07

企业合并公告

425 - Prospectuses and communications, business combinations
2021/11/30

SEC问询函

CORRESP [Cover] - Correspondence